Related Experiment Video
Updated: Sep 12, 2025

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Vancomycin-resistant enterococcal infections in liver transplant recipients: Clinical impact and therapeutic
Nicole C Vissichelli1, Aldo Barajas-Ochoa2, Megan K Morales1
1Division of Infectious Diseases, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
Abstract:
Vancomycin-resistant Enterococci (VRE) are an important cause of infection in liver transplant recipients and are associated with significant morbidity and mortality. Liver transplant candidates and recipients share various risk factors for VRE infections, and colonization has been shown to be associated with increased risk for infection. With limited antimicrobial options and data available for guidance, treatment can be challenging. This review discusses the epidemiology of VRE infections in patients with end-stage liver disease and after liver transplant, as well as therapeutic approaches.
Insights
Vancomycin-resistant Enterococci (VRE) infections pose a significant threat to liver transplant recipients. This review covers VRE epidemiology and treatment strategies for these vulnerable patients.
Area of Science:
- Infectious Diseases
- Transplantation Medicine
- Microbiology
Background:
- Vancomycin-resistant Enterococci (VRE) are a major cause of infection in liver transplant recipients.
- VRE infections in this population are linked to high rates of illness and death.
- Colonization with VRE increases the risk of developing VRE infection.
Purpose of the Study:
- To review the epidemiology of VRE infections in patients with end-stage liver disease and liver transplant recipients.
- To discuss current therapeutic approaches for VRE infections in liver transplant patients.
Main Methods:
- Literature review of VRE epidemiology and treatment in liver transplant recipients.
- Synthesis of data on risk factors, colonization, and infection outcomes.
- Analysis of available antimicrobial options and treatment challenges.
Main Results:
- VRE infections are a significant concern in liver transplant recipients.
- Shared risk factors exist between liver transplant candidates and recipients for VRE.
- Limited treatment options and data complicate VRE management.
Conclusions:
- Understanding VRE epidemiology is crucial for managing infections in liver transplant recipients.
- Effective therapeutic strategies are needed due to limited antimicrobial choices.
- Further research is warranted to improve VRE treatment outcomes in this patient group.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Hepatic Drug Excretion: Influencing Factors
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

